Accelerated Death Benefit vs. Viatical Settlement: Which Pays More?

When someone receives a serious diagnosis and mentions it to their insurance company, the carrier will often point them toward a rider already attached to the policy: an accelerated death benefit. It is presented as the obvious move, and in a lot of cases it genuinely is. It is fast, it requires no third party, and the money can be in hand in weeks.

What rarely comes up in that conversation is that the acceleration is not the only way to turn the policy into money, and it is not always the one that produces the larger number. The carrier has no obligation to mention the alternative, because the alternative involves selling the policy to somebody else.

This is a comparison of the two, written so you can work out which applies to you before anything is signed. Both routes are legitimate. They simply answer different questions.

What an Accelerated Death Benefit Is

An accelerated death benefit lets the policy owner draw part of the death benefit early, while the insured is still living, once a qualifying illness has been certified. Almost every modern policy has some version of it, often included at no extra premium, and many people do not know they have it until they ask.

The important thing to understand is where the money comes from. It is not a separate benefit and it is not a loan against cash surrender value. It is your own death benefit, paid to you sooner, and the amount taken is subtracted from what your beneficiaries eventually receive.

Riders come in a few flavors, and which one you have determines both what you must prove and how much you can take:

• Terminal illness. The most common trigger. A physician certifies a condition reasonably expected to result in death within a set window, commonly 12 or 24 months depending on the rider and the state. The federal tax rules use a 24 month standard, which the IRS sets out in its Form 1099-LTC instructions.
• Chronic illness. No prognosis is involved. A health care practitioner certifies that the insured cannot perform at least two activities of daily living without substantial assistance for at least 90 days, or requires substantial supervision because of severe cognitive impairment.
• Critical illness. Less common. Triggered by a listed event such as a heart attack, stroke or specific cancer diagnosis, regardless of prognosis.

Each of these is a different door, and a policy may have one, two or none of them. The rider language governs, not the general description a call center gives you.

How Much It Actually Pays

This is where expectations and reality separate. People often assume an acceleration means access to most of the policy. Sometimes it does. Frequently it does not.

Carriers cap acceleration in two ways at once, and whichever is lower wins. There is a percentage limit on the face amount, which commonly falls somewhere between 25 percent and 100 percent depending on the carrier and the trigger. And there is often a flat dollar ceiling that applies no matter how large the policy is, which is what quietly limits the biggest policies most.

Terminal illness riders generally allow larger accelerations than chronic illness ones. Chronic illness riders frequently pay in monthly installments rather than a lump sum, which matters a great deal if the money is needed for something immediate.

There is no way to estimate this from the outside. Ask the carrier, in writing, for the maximum accelerated amount available on your specific policy today and whether it is paid as a lump sum or in installments. That single figure is the number that makes the rest of this comparison possible.

What the Acceleration Costs

The figure the carrier quotes as the accelerated amount is not the figure that arrives in your account, and the gap between them is the part most people are surprised by.

Because the carrier is paying money it expected to hold for some further period, it charges for the time. That happens one of two ways. Some carriers apply an actuarial discount, reducing the payment to its present value. Others record a lien against the policy for the full accelerated amount plus accruing interest, then recover the lien from the death benefit at claim. Either way, the death benefit is reduced by more than the cash you receive.

On top of that, most carriers deduct an administrative fee, and many states cap it. The fee is usually modest in absolute terms. The discount or lien interest is the part that moves the number.

So the honest arithmetic on an acceleration has three steps: the percentage of face you are allowed to take, minus the discount or lien cost, minus the fee. Ask for all three before comparing anything.

How a Viatical Settlement Differs

A viatical settlement is a sale rather than a withdrawal. The policy is transferred to an institutional buyer, the buyer pays a lump sum and takes over all future premiums, and the buyer receives the death benefit when the insured dies. Nothing is left behind for the original beneficiaries.

The distinction from a standard life settlement is health, not age. A viatical settlement involves an insured who has been certified terminally or chronically ill; a life settlement typically involves someone 65 or older whose health has simply changed since the policy was issued. Our full comparison of life settlements and viatical settlements covers where the line falls.

Two structural differences drive most of the payout gap between a settlement and an acceleration.

The first is competition. An acceleration is priced by one company, the one that already holds the policy, using terms written into the contract years ago. A settlement is priced by multiple institutional buyers bidding against each other on the same file. That is the entire reason people work with life settlement specialists rather than approaching a single buyer.

The second is scope. An acceleration reaches a slice of the death benefit. A settlement reaches the whole policy. Buyers value a policy on face amount, projected premiums and life expectancy, which is why a policy with a shortened life expectancy can command a meaningful share of face. Our breakdown of how life settlement payouts are calculated walks through the inputs.

A settlement also ends the premium obligation permanently. That is easy to overlook and it is often worth a great deal, because an acceleration leaves the residual policy in place and the premiums still have to be paid to keep it there.

The Two Side by Side

How Each One Is Taxed

This is the part where the two routes look more alike than people expect, and it is worth understanding because a difference in tax treatment can outweigh a difference in headline amount.

Both sit under the same provision. Internal Revenue Code section 101(g) treats qualifying accelerated death benefits, and qualifying viatical settlement proceeds, as though they were paid because of the insured's death. Payments that qualify are generally excluded from gross income.

For a terminally ill insured, the exclusion is generally unlimited. For a chronically ill insured, payments made on a periodic basis without regard to actual expenses are subject to an annual per diem cap. For 2026 that cap is 430 dollars per day, set in IRS Revenue Procedure 2025-32. Payments above the cap are taxable only to the extent they also exceed what was actually spent on qualified long-term care.

For a viatical settlement, the exclusion depends on the transaction meeting the statutory requirements, including the certification and the standing of the provider buying the policy. Where those conditions are not met, the proceeds fall back to the ordinary rules covered in our guide to the tax implications of a life settlement, and our post on whether viatical settlement proceeds are taxable goes through the conditions in more detail. The IRS covers both in Publication 525.

One thing that is not a tax question but gets tangled up with one: money from either route becomes a countable asset once it reaches a bank account, which can affect eligibility for needs-based programs. Anyone on Medicaid or Supplemental Security Income should raise that separately with a benefits counselor or an elder law attorney. None of this is tax advice, and both routes are worth running past your own tax professional before you commit.

Which One Fits Your Situation

The comparison usually resolves on three questions, and they are worth answering in order.

Does anyone still need the death benefit? If a spouse, a dependent adult child, or an illiquid estate genuinely depends on the policy paying out, an acceleration preserves something and a sale does not. That can settle the question on its own, and if you are unsure, our guide to whether you still need your policy works through it. If nobody needs it, the residual benefit an acceleration protects is not worth much to you.

How much money is actually needed, and how fast? An acceleration is generally the faster route, sometimes by a wide margin. If the need is immediate and the accelerated amount covers it, speed can be worth more than the difference in total. If the need is larger than the rider allows, the acceleration may not solve the problem at all.

Can the premiums keep being paid? This is the one people miss. An acceleration leaves a reduced policy that still requires premiums, and if those premiums were already a strain, the situation returns in a few months. A sale removes the obligation entirely. If premiums are the underlying pressure, our post on what to do when premiums become unaffordable covers the wider set of options.

Where the money is needed for care specifically, there is a third route worth knowing about alongside these two, covered in our guide to using a life insurance policy to pay for long-term care.

Why the Order Matters

If you take anything practical from this, take this: check both before doing either.

An acceleration reduces the death benefit, and buyers price a policy on the death benefit that remains. So accelerating first shrinks whatever a settlement could later pay, sometimes substantially. Going the other way is not possible either, because once the policy is sold you no longer own the rider.

Neither decision can be undone. The sequence that keeps both options open is to get the carrier's accelerated figure in writing, get an indication of what the policy would bring on the secondary market, and then compare two real numbers rather than one real number and one assumption. Not every policy qualifies for a settlement, and our post on what disqualifies a policy sets out the common reasons, so it is worth checking rather than assuming either way.

What to Do Before You Decide

A short list, in the order that keeps the most options available:

• Get the rider in writing. Ask the carrier for the maximum accelerated amount on your policy today, the discount or lien terms, the administrative fee, and whether payment is a lump sum or installments. Those four items are the whole offer.
• Confirm what certification exists. The trigger the rider requires and the certification your doctor has actually written are not always the same thing, and that gap decides which routes are open.
• Find out what the policy is worth on the secondary market. A valuation costs nothing and does not commit you to selling. The National Association of Insurance Commissioners publishes consumer guidance on how these transactions are regulated, and the Life Insurance Settlement Association maintains background on how the market operates.
• Check the benefits question separately. Tax treatment and benefit eligibility are different tests, and the second one catches people out.
• Then compare. Net cash from the acceleration, residual death benefit and remaining premiums on one side. Lump sum, no death benefit and no premiums on the other.

Carriers are not doing anything improper by leading with the rider. It is a real benefit, it is often the right answer, and it is the one they can offer. It is simply not the only one, and the comparison is yours to make. You can see the general criteria on our eligibility page, or ask us to look at the specific policy.